Cargando…
Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease
BACKGROUND: Data regarding long-term association of metabolic syndrome (MetS) with adverse outcomes are conflicting. We aim to determine the independent association of MetS (based on its different definitions) with 20 year all-cause mortality among patients with stable coronary artery disease (CAD)....
Autores principales: | Younis, Arwa, Younis, Anan, Tzur, Boaz, Peled, Yael, Shlomo, Nir, Goldenberg, Ilan, Fisman, Enrique Z., Tenenbaum, Alexander, Klempfner, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084328/ https://www.ncbi.nlm.nih.gov/pubmed/27793156 http://dx.doi.org/10.1186/s12933-016-0466-6 |
Ejemplares similares
-
Impaired Fasting Glucose Is the Major Determinant of the 20‐Year Mortality Risk Associated With Metabolic Syndrome in Nondiabetic Patients With Stable Coronary Artery Disease
por: Younis, Arwa, et al.
Publicado: (2017) -
Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial
por: Arbel, Yaron, et al.
Publicado: (2016) -
The addition of vildagliptin to metformin prevents the elevation of interleukin 1ß in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, open-label study
por: Younis, Arwa, et al.
Publicado: (2017) -
Type 2 diabetes mellitus increases the mortality risk after acute coronary syndrome treated with coronary artery bypass surgery
por: Ram, Eilon, et al.
Publicado: (2020) -
Ethnic Disparity in Mortality Among Ischemic Heart Disease Patients. A-20 Years Outcome Study From Israel
por: Abu-Much, Arsalan, et al.
Publicado: (2021)